Akers Biosciences Completes Clinical Trial for Rapid Chlamydia Test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. SPY
7. APLD
8. ORCL
9. USO
10. STZ

Go back to Akers Biosciences Completes Clinical Trial for Rapid Chlamydia Test

Akers Biosciences (AKER) Shares Pop Higher Upon Completion of PIFA/Chlamydia Rapid Assay Clinical Trial

June 30, 2016 9:00 AM EDT

Akers Biosciences (Nasdaq: AKER) shares are popping higher in early trading after the company announced that it completed a clinical trial of its PIFA/Chlamydia Rapid Assay, the first rapid test for Chlamydia diagnosis using a finger stick blood sample.

Akers is up over 17 percent ahead of the opening bell.

... More